Bayer Pharma Sale Remains Long-Term Option; CFO Wenning To Become CEO

Bayer AG is leaving open the possibility of a sale of its pharmaceutical division over the long-term, while emphasizing that it remains a "core" business for now.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet